[1]
P. Ramya, M. Srinivas, and B. Udaya Kumari, “Development of a Validated RP-HPLC/UV Method for the Quantitative Determination of Tyrosine Kinase RET Inhibitor: Selpercatinib in Capsule Formulation”, J. Drug Delivery Ther., vol. 14, no. 7, pp. 57–63, Jul. 2024, doi: 10.22270/jddt.v14i7.6702.